Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Remyelination Therapy for Multiple Sclerosis.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
PML risk stratification using anti-JCV antibody index and L-selectin.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
The grey matter correlates of impaired decision-making in multiple sclerosis.
The history of neuromyelitis optica.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Fine-Tuning S1P Therapeutics.
Abnormal Baseline Brain Activity in Patients with Multiple Sclerosis With Simple Spinal Cord Involvement Detected by Resting-State Functional Magnetic Resonance Imaging.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Diverse functional roles of lipocalin-2 in the central nervous system.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.
The induction of Treg cells by gut-indigenous Clostridium.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »